Patent details

Basic Information

Publication number:

EP2854858

PCT Application Number:

EP2013061320

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP137260030

PCT Publication Number:

WO2013178812

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

RISPERIDONE IMPLANT FORMULATION

French Title of Invention:

FORMULATION POUR IMPLANT CONTENANT DE LA RISPÉRIDONE

German Title of Invention:

RISPERIDON- IMPLANTATFORMULIERUNG

SPC Number:

Dates

Filing date:

31/05/2013

Grant date:

10/12/2025

EP Publication Date:

08/04/2015

PCT Publication Date:

05/12/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/12/2025

EP B1 Publication Date:

10/12/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

31/05/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/12/2025

 

 

Name:

Laboratorios Farmacéuticos Rovi, S.A.

Address:

C/ Julián Camarillo 35, 28037 Madrid, Spain (ES)

Agent

Name:

ELZABURU SLP

From:

18/02/2026

Address:

To:

Inventor

1

Name:

FRANCO RODRÍGUEZ, Guillermo

Address:

Spain (ES)

2

Name:

GUTIERRO ADURIZ, Ibon

Address:

Spain (ES)

Priority

Priority Number:

12170362

Priority Date:

31/05/2012

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 47/34;

Publication

European Patent Bulletin

Issue number:

202550

Publication date:

10/12/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/06/2026

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
17/02/2026	Power Of Attorney	1
18/02/2026	Outgoing Correspondence	1